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Treatment guidelines recommend home treatment (HT) as an effective alternative to
inpatient treatment for individuals with severe, acute mental illness (SAMI). Nevertheless,
HT is largely unfamiliar in German-speaking countries. Here we examined the utilization
and effectiveness of HT services newly implemented in a large hospital setting in
Switzerland. We used a naturalistic observational study design including patients (n =
201, 18–65 years, 65.7% females) with SAMI who received HT between June 2016
and December 2017. HT patients were compared with a crude inpatient sample (n =
1078) and a matched inpatient sample (n = 201). Propensity-score matching was used
to control for personal characteristics. Treatment outcomes were compared between
HT patients and the matched inpatients based on routinely obtained medical data. The
results showed that the HT sample consisted of more females (+21%), older (+4 years),
and better educated (+10%) patients with more affective disorders (+13%) and less
substance use disorders (−15%) as compared with the crude inpatient sample. The
severity of symptoms was the same. After matching, there were no significant differences
in the proportion of readmissions (36%), the duration until readmission and scores
of the Health of the Nation Outcome Scales (HoNOS). The treatment duration of HT
patients was significantly longer and, post-treatment, scores on the Global Assessment
of Functioning scale (GAF) were significantly better. We conclude that HT is an effective
treatment option for patients with SAMI also in Switzerland concerning the reduction of
hospital days, the improvement of symptoms and functioning and readmission rates.
HT cannot fully replace hospital admissions in all cases and HT may be beneficial for
particular groups of patients (e.g., females and individuals with affective disorders). The
study further shows the potential value of propensity-score matching in health care
service research.
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INTRODUCTION
Home treatment (HT) is an evidence-based alternative to
inpatient treatment for patients with a severe, acute mental illness
(SAMI) and is explicitly recommended by current treatment
guidelines (1, 2). Instead of a hospital stay, patients are treated
at their homes by a multidisciplinary and mobile professional
team in episodes of acute mental illness (3, 4). Unlike to English-
speaking (e.g., U.K., USA, Canada) and other countries such as
Norway, Italy, France, and the Netherlands, HT services have not
yet been widely established in German-speaking countries (5),
most likely due to different cultural backgrounds and psychiatry
service histories. Therefore, it is unclear whether HT is as
effective as inpatient treatment in Switzerland, considering its
particular financing and care structures (6).
In 2016, the University Hospital of Psychiatry Zurich, which
is the largest psychiatric hospital in Switzerland, established HT
services with capacity of up to 18 patients at a time. These
HT services are intended as an alternative for patients with
SAMI—patients with illness duration > 2 years and Global
Assessment of Functioning (GAF) scores < 50 (7)—and need
for inpatient treatment who are aged between 18 and 65 years,
voluntarily admitted and with permanent residence in the urban
and periurban surrounding of the city of Zurich. Patients can
be assigned to HT by resident physicians or change to HT after
initial or intermediate inpatient stays. There are no predefined
exclusion criteria for any diagnoses, however, HT services are
limited to patients with health insurance companies that agreed
to pay for this service, which is true for about 50% of all health
insurances. Moreover, patients with delirious syndromes and
acute intoxications are excluded as well as acute risk of self-harm
or harm to others. In case a patient meets the criteria for HT,
the physician in charge discusses this treatment option with the
patient considering his or her preferences and the HT occupancy
rate.
The multiprofessional HT team consisting of physicians,
nurses, one psychologist, one occupational therapist, and one
social worker provides daily home visits, i.e., at least one
(up to three) visit by nursing staff per day, and at least two
consultations by physicians per week. If desired, patients can
also use other hospital services (e.g., physical exercise therapy,
vocational therapy, internal medicine). The team offers 24/7
accessibility.
The HT implementation is in line with the model guidelines
described by Gühne et al. (8). Key characteristics of such
services are mobile and multiprofessional teams, rapid access,
frequent home visits, a 24-h service and the provision of
different treatments, such as medical, psychological and social
interventions (9). The HT team also has a “gatekeeping”—
function, which aims to prevent unnecessary hospital admissions
(8). The treatment duration should be similar to hospital stays
(5). Although there are no strict exclusion criteria, HT is not
suitable for uncooperative patients and individuals at risk of self-
harm or harm to others (10). Previous research showed that HT
can reduce inpatient stays and hospital admissions during acute
episodes. Studies also demonstrated that HT was associated with
improved cost-effectiveness, satisfaction of patients and relatives
and reduced withdrawals when compared to treatment-as-usual
(8, 11–13). In particular, patients with children often are
interested in being treated at home (14). However, more evidence
is needed concerning treatment duration, readmission rates,
psychosocial outcomes, and characteristics of HT users (5).
Although randomized controlled designs are considered as
“gold standard” to estimate causal treatment effects, such trials
are not always feasible due to ethical or logistical reasons (15,
16). Moreover, limitations referring to external validity must
be considered. For naturalistic observations, there are good
statistical methods such as regression models or propensity-
score (PS) matching that can be used to control covariates for
interfering causal links between intervention and outcomes (17–
19). PS matching reduces the number of covariates that need
to be controlled for in the outcome model. When appropriately
applied, PS matching can produce the same results as obtained by
randomized controlled designs (20, 21).
Here we addressed two scientific general goals: (1) to
investigate service utilization in routine care by comparing
patients’ characteristics between the HT sample and the crude
inpatient sample and (2) to examine the effectiveness of HT
services by comparing treatment outcomes between the HT
sample and a matched inpatient sample. For these purposes,
a naturalistic observational study-design with PS matching
analysis was applied using routinely obtained medical data.
We were interested in the following outcomes: treatment
duration, reduction of symptoms and increase of functioning,
circumstances at discharge, proportion of readmissions, duration
until the next readmission, and duration of the readmission
period. As HT provides the same range of therapies as the
conventional inpatient treatment, we hypothesized that the
effectiveness of HT is not inferior to inpatient treatment.
MATERIALS AND METHODS
Sample and Data Collection
The present study included all patients who were treated in
either HT or hospital during the study period from June 2016
until December 2017 and meeting the inclusion criteria provided
below. We wanted to examine a study period of at least 1 year to
compensate for monthly variations including a 6-month follow-
up period to calculate the readmission rates. In compliance
with the guidelines of the implemented HT services, we set
the following inclusion criteria: Patients had to be between
18 and 65 years of age, in need of inpatient treatment, and
of a treatment duration of 48 h or more, voluntarily admitted
or transferred from inpatient setting voluntarily, and with a
permanent residence.
The HT-setting included 201 patients who received 239
treatment episodes. In case when the same patients were treated
more than once during the study period, we included only the
primary treatment episode (= first case) of each HT patient.
Thus, the final sample included n = 201 treatment episodes of
different HT patients. A treatment episode encompassed the sum
of all days treated in HT and if required hospital days directly
before, during or after HT.
The control group included in-patients who have been treated
only in hospital during the study period in one of the eight wards
of the Center for Acute Psychiatric Disorders of the University
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Hospital of Psychiatry Zurich and who met the above-mentioned
inclusion criteria. The sample of the control group included n
= 1078 in-patients who received 1,459 treatment episodes in
hospital. Again, we selected only the primary treatment cases.
We also excluded other cases of patients that had been treated
both in hospital and in HT during the study period in order to
avoid that those cases would get matched with themselves. The
crude inpatient sample therefore included n = 1078 treatment
episodes of different inpatients. The matched inpatient sample
was selected from the crude inpatient sample and, consequently,
included n= 201 inpatients.
We retrieved the data from routine medical data records of
the patients. These data have to be collected by federal law in
Switzerland (22). Trained physicians who were in charge at the
time of the patients’ admission and discharge assessed the data.
We checked reliability and validity of the data by comparing
selected variables with those obtained from other data sources
(e.g., accounting systems). The use of such routine data for
evaluating health care services has the advantage of providing
comprehensive and objective data for every patient (23).
As the data of interest were anonymized prior to access to the
study, approval of an institutional review board was not required
according to the relevant regulations. The local ethic committee
KEK provided a declaration of non-competence for this study.
Control and Outcome Measures
Control Variables
We used the following mentioned control variables to compare
the HT sample with the crude inpatient sample and selected them
based on (theoretical) associations with both, the assignment
to the treatment modality (HT vs. inpatient treatment) and
the outcome variables (24). First, we selected sociodemographic
variables (gender, age, education, employment status, and
Swiss citizenship) and psychiatric diagnoses (main psychiatric
diagnosis and number of secondary diagnoses) which were
associated with levels of symptoms assessed by the Health of the
Nation Outcome Scales (HoNOS) in previous research of the
same population (25). Total score on the HoNOS at admission,
HoNOS items 1-3 at admission (problems due to harm to others,
risk of self-harm, problems related to drug use), GAF score at
admission and number of previous hospital stays were used as
control variables in line with HT guidelines that emphasize that
HT is an alternative for in-patients with severe mental illness, but
less suitable for patients at risk for self-harm, risk to others, and
problems related to drug use (8–10). The HoNOS range from 1
to 48, with higher scores denoting worse health (26). The GAF
scale ranges from 1 to 100 with higher scores indicating better
functioning (27).
The following variables were dichotomized and used as
matching variables in the PS analysis: gender (male vs. female),
education (higher educated [grammar school, higher vocational
education, university] vs. other [no education, compulsory
education, vocational education, unknown], employment status
(employed vs. unemployed), citizenship (Swiss citizenship vs.
other), F1 diagnosis (yes vs. no), F3 diagnosis (yes vs. no),
secondary diagnoses (present vs. not present), and HoNOS items
1–3 at admission (yes vs. no). Age, HoNOS total score and
number of previous hospital stays were used for the PS matching
on a continuous scale. Further variables such as F2 diagnosis
or GAF scores were not used as matching variables in the
final model as they provided no additional value for achieving
balanced groups.
Outcome Variables
We assessed the following outcome variables for both, the HT
sample and the matched inpatient sample: Treatment duration,
levels of symptoms and functioning, circumstances of discharge,
proportion of readmissions, duration until the next readmission,
and duration of the readmission period. We calculated the
total treatment duration of the HT patients by summing up all
treatment days that the patients received in the HT-setting and
the inpatient setting (directly before, during, and after HT) of
each treatment episode. The following measures were assessed
at discharge to determine the severity of symptoms and level of
functioning: Health of the NationOutcome Scales (HoNOS) (26),
Global Assessment of Functioning (GAF) scale (27), and Clinical
Global Impression (CGI) improvement scale (2–4= improved, 5
= no change, and 6–8 = worse) (28). In HT patients, HoNOS,
GAF and CGI were assessed at admission and at discharge of
the entire treatment episode, independent of whether they had
been treated in an inpatient setting before or after receiving HT.
Missing values on these scales were due to treatment durations
<7 days where scales were not completed (22). Circumstances
at discharge were assessed by the proportion of patients who
terminated treatment bymutual agreement and the proportion of
patients who were able to stay at home after discharge. Treatment
duration, duration until the next readmission and duration of
the readmission period were measured in whole days. Variables
related to readmission were reported for cases treated between 1
June 2016 and 30 June 2017 to ensure a follow-up period of at
least 6 months after discharge.
Statistical Analyses
Before PS matching, differences in control variables between the
HT sample and the crude inpatient sample were tested using t-
tests and chi-squared tests for independent samples. Given 201
patients (alpha = 0.05, beta = 0.80), we could expect to find
differences of small effects (29). After the PS matching, we used t-
tests and McNemar-tests for dependent samples. We applied PS
matching using a 1:1 ratio with the nearest neighbor matching
procedure without replacement. This method is recommended
if sample size of the control group is at least 3–4 times larger
than that of the treatment group, which was the case in the
present study (30). (Other selection procedures, such as optimal
matching using 1:2 ratio and caliper matching with a standard
deviation-width equal to 0.2 of the logit of the PS produced
less balanced samples). We conducted the PS matching analysis
following the recommendations of Olmos and Govindasamy (30)
and Randolph (31), including a balance check of the matching
results and sensitivity analysis of three main outcomes. For
the balance check of the matched groups, we performed an
omnibus chi-square test (32). In addition, we examined the
standardized differences between the two groups for all control
variables, which should be smaller than 0.25 (33). We performed
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a sensitivity analysis based on themethod of Rosenbaum to detect
biases not identified in the results of non-parametric tests. A
gamma value close to 1 indicates that the results are sensitive to
bias (34). We used R software (35) with the package matchIt (36)
for estimating PS by logistic regression and the packages RItools
(37) and matching (38) for balance and sensitivity checks. Other
statistical analyses were performed using IBM SPSS, version 23
for Windows (IBM Corp. 2015). Statistical significance was set at
the 5% level.
RESULTS
Utilization of HT and Sample Description
Between June 2016 and December 2017, 201 patients received
HT, of whom 54.2% were assigned directly to HT and 45.8%
were assigned to HT after inpatient treatment in a psychiatric
ward. Only 25 (12.4%) patients needed hospital days during or
after HT. These patients were more likely to have a substance
use disorder (F1 diagnosis) and less likely to have an affective
disorder (F3 diagnosis) than HT patients without inpatient days
(p < 0.05). Direct admissions were 1.5 times more likely to have
an affective disorder (F3 diagnosis) and 2.7 times less likely to
have a risk of self-harm compared to admissions via psychiatric
wards. Table 1 (c.f. column “Inpatients before matching”) shows
differences in the control variables between the HT sample
and the crude inpatient sample. HT patients were on average
older, better educated and characterized by a greater proportion
of females and Swiss citizens. In addition, HT patients had
more often an affective disorder (F3 diagnosis) and less often
a substance use disorder (F1 diagnosis). Patients who received
HT did not differ from inpatients with respect to the presence
of secondary diagnoses, severity of symptoms and levels of
functioning (HoNOS item 1-3, HoNOS total, GAF), and the
number of previous hospital stays.
FIGURE 1 | Distribution of Propensity Scores of HT patients (Matched
Treatment Units, n = 201) and inpatients (Matched Control Units, n = 201 and
Unmachted Control Units, n = 877).
Goodness of PS Matching
In order to reduce the initial selection bias, the HT sample
was 1:1 matched with inpatients selected by PS. Graphical
and statistical results of the balance check indicated that PS
matching worked very well (c.f. Figure 1). The non-significant
chi-square value indicated that the groups were balanced in
terms of all control variables (X2 = 5.62 (13), p = 0.959) (32).
The mean distance of all the control variables between the
HT and inpatient group was reduced from 0.0828 to 0.0010,
while lower quartile-differences indicated better matching (31).
Standardized mean differences of all the control variables were
small and varied between 0.00 and 0.13 (24). As expected,
based on these imbalance indices, the control variables did
not significantly differ between the HT sample and the
matched inpatient sample (Table 1; c.f. column “Inpatients after
matching”).
Comparison of Outcome Variables
Between the Matched Samples
Details on differences in outcome variables between the two
treatment modalities are shown in Tables 2,3. Average treatment
duration of the HT patients was 40.5 days and significantly
longer than that of the matched inpatient sample (M = 26.2).
HT patients had significantly fewer hospital days (M = 10.3)
of which 7.8 days were prior to the patient’s transferring to
HT. Changes in symptom severity and levels of functioning
indicate treatment success in both groups: HoNOS and GAF
values were significantly better at discharge in HT patients
(HoNOS: M = 14.1 [p < 0.001]; GAF: M = 67.6 [p <
0.001]) and in inpatients (HoNOS: M = 15.0 [p < 0.001];
GAF: M = 59.0 [p < 0.001]) than at admission (HoNOS:
M = 19.0; GAF: M = 41.0 [HT patients]); HoNOS: M =
18.6; GAF: M = 42.4 [inpatients]). At discharge, GAF values
were significantly better in the HT sample, but the HoNOS
and CGI values did not differ between the two treatment
modalities. The majority of patients in both samples were
able to stay at home after the end of treatment, with only
a small percentage placed in a residential home or referred
to another psychiatric or somatic hospital. The proportion
of patients who terminated treatment by mutual agreement
was significantly higher in HT patients than in inpatients.
Further reasons for treatment termination in HT vs. inpatients
were the physician’s own initiative (4 vs. 6.5%), the patient’s
own initiative (3.5 vs. 8%), absconding (0.5 vs. 3%), suicide
(1 vs. 0.5%), and other reasons not specified (3.5 vs. 3.9%).
Table 3 shows that there was no significant difference in the
proportion or total number of readmissions, the duration until
the next readmission and the duration of the readmission
period between the HT patients and the inpatients admitted
between June 2016 and June 2017. This was also true when
all cases (n = 402) were included of the observation period
between June 2016 and December 2017. Additionally, the
results of the sensitivity analysis indicated that the findings
were overall stable with no hidden biases (gamma values for
treatment duration, duration until the next readmission and
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TABLE 2 | Hospitalization and quality indicators of treatment of matched samples, separated by treatment modality during a 19-month period.
HT Inpatients
n = 201 n = 201 Chi-Square or T-value
Outcome variables % or Mean SD % or Mean SD df P-value
Treatment Duration, Days
Total treatment episode 40.5 27.3 26.2 21.8 6.12 200 < 0.001
Home treatment vs. inpatient days 30.2 19.1 26.2 21.8 2.09 200 0.038
Inpatient days 10.3 20.0 26.2 21.8 7.70 200 < 0.001
HoNOS total, at discharge 14.1 6.5 15.0 6.3 1.45 146 0.150
GAF scale, at discharge 67.4 17.8 59.0 16.7 4.79 192 < 0.001
CGI Improvement Scale, at Discharge
Improved 90.5a 89.6a 1.23 3 0.745
No change 8.0a 8.9a
Worse 1.5a 1.6a
Mutual agreement of treatment termination 87.5 78.1 0.020
At home after discharge 82.6 78.6 0.382
T-tests for dependent samples and McNemar tests were used.
Identical letters indicate no statistically significant difference by Bonferroni-adjusted Chi-square post-hoc tests at P < 0.05.
HoNOS = Health of the Nation Outcome Scales (1-48; higher values = worse); GAF = Global Assessment of Functioning (1-100; higher values = better); CGI = Clinical Global
Impression.
TABLE 3 | Readmissions of matched samples of treatment period between 1 June 2016 and 30 June 2017, separated by treatment modality.
HT Inpatients
n = 103 n = 103
Outcome variables M or % SD M or % SD Chi-Square or T-value df p-value
Proportion of readmissions 36.9 35.9 1.000
Number of readmissions 0.9 1.9 1.1 2.2 0.49 102 0.623
Duration until the next readmission, daysa 295.1 162.7 271.0 160.9 1.09 102 0.279
Duration of the readmission period, daysb 9.6 21.8 11.1 25.8 0.46 102 0.648
T-tests for dependent samples and McNemar test were used.
aData are right-censored by end of December 2017.
bDuration = 0 of data without readmissions; real duration: MHT = 29.1 days and MInpatients = 32.6 days.
total number of readmissions changed to significance at 1.5 and
higher) (34).
DISCUSSION
This study investigated the utilization and effectiveness of HT by
comparing routinely obtained medical data of HT patients with
a crude inpatient sample and a 1:1 PS-matched inpatient sample.
Naturalistic observations showed that the patients who received
HT differed from inpatients receiving conventional treatment
in some respects, including sociodemographic variables and
psychiatric diagnoses, but not with respect to severity of
symptoms and level of functioning at admission. These finding
suggests that particularly females and elderly persons with an
affective disorder consider HT as a valuable alternative to a
conventional inpatient treatment for themselves. Thus, patients’
treatment preferences might be also important to consider
for HT indication. However, previous research showed that
sociodemographic and diagnostic variables were less relevant for
treatment success of HT than being uncooperative and at risk of
self-harm and harm to others (10). The latter factors did not differ
between HT patients and inpatients.
Overall, the results of the PS analysis based on administrative
and clinical outcomes indicated that HT seemed to be an effective
treatment option for individuals with SAMI as suggested by
previous research conducted in other countries (8, 11, 12). PS
matching reduced the number of covariates to compare the
HT patients with a similar inpatient sample. More precisely,
HT was associated with a substantial reduction of hospital
days and mean duration of the HT episodes was within the
recommended time span of four to six weeks (5). Nevertheless,
HT duration was on average 2 weeks longer than the duration
of inpatient treatment. In future, HT episodes could possibly be
reduced by enabling a smoother and more rapid transition from
hospital admission to HT as hospital days before HT accounted
for 19.3% of the treatment duration in total. Both HT and
inpatient treatment showed the same reduction of symptoms
and increase of functioning assessed by the HoNOS (26) and the
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CGI improvement scale (28). The level of functioning of the HT
patients at discharge was even better than that of the inpatients, as
assessed by the GAF scale. This is an important finding, because
one of the major goals of HT is the provision of practical support
in the context of an individual’s social and physical environment
to stabilize and improve levels of functioning (8, 9). It may
also be explicable by the fact, that the HT patients are assessed
concerning functioning in their own domestic environment.
It can be assumed that patients would show higher levels of
functioning compared to the inpatient setting. In addition, the
proportion of treatment termination by mutual agreement was
higher in HT patients, which might be an indication of treatment
satisfaction and a good therapeutic relationship. However, this
cannot be confirmed by the present study as no respective scales
were applied. In most studies, treatment satisfaction has been
reported to be higher for HT services compared to inpatient
treatment (12). Furthermore, there were no between-group
differences in the outcomes concerning readmissions such as
the proportion of readmissions and the duration until the next
readmission indicating long-term effectiveness of HT beyond the
treatment episodes.
This study was based on routinely obtained medical data,
and, thus, specific data such as the patients’ satisfaction and the
burden of their cohabitants could not be analyzed. Despite the
many advantages of routine data in health care service research,
another drawback of routine data might be its uncertain quality
(23). To address this issue, we carefully checked the reliability
and validity of the data by comparing them with other data
sources. Based on this assessment, data quality was considered
sufficiently high. A further limitation of the study might be its
observational study design for drawing causal conclusions. For
instance, the uniqueness of the multiprofessional HT team may
have influenced the results. In contrast to randomized controlled
designs, the outcome assessment was non-blinded. However,
sophisticated PS matching is considered a good method to
remove selection bias in observational studies when randomized
controlled designs are not feasible, potential confounders are
known, and the sample size of the control group is sufficiently
large (30). In this study, the sample size of potential control
cases was very large, and the balance check pointed to successful
PS matching. The sensitivity analysis further suggested that the
results are robust. All data were collected from only one hospital
in Switzerland, thus, results may not be generalized for the whole
country. However, the examined HT services are included in one
of the largest psychiatric hospitals in Switzerland with an urban
and periurban catchment area.
In conclusion, HT seems to be an effective alternative to
inpatient treatment also in a Swiss urban region for a wide range
of patients with SAMI concerning the reduction of hospital
days, the improvement of symptoms and functioning and
readmission rates. Although HT reduces the need for inpatient
stays, it cannot fully replace hospital admissions in all cases.
Besides medical aspects, some groups of patients (e.g., women,
patients with affective disorders) might be particularly interested
in HT services. Further studies are needed to examine other
aspects of effectiveness, for instance including cost-effectiveness,
patients’ satisfaction and treatment interventions of HT
services.
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